Researchers have discovered a rare new type of diabetes that affects babies early in life. The condition is caused by changes ...
Biomea Fusion (NASDAQ:BMEA) highlighted two clinical-stage programs focused on diabetes and obesity during a presentation at ...
A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...
Residual CFTR function in cystic fibrosis was associated with better glucose tolerance and insulin secretion, with CFTR ...
Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes. Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage ...
We always relate diabetes to aged people or obese individuals, while scientists have discovered some shocking facts about ...
Sanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D ...
European Commission approves Sanofi’s Teizeild to treat patients with stage 2 type 1 diabetes: Paris Tuesday, January 13, 2026, 11:00 Hrs [IST] The European Commission has appro ...
Advancing icovamenib toward late-stage clinical development in two Phase II clinical trials in patients with insulin-deficient type 2 diabetes (“T2D”) and in T2D patients currently failing ...
To make it easier to pull a .csv or .txt file directly into Excel without having to deal with Power Query, Microsoft is ...
Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.
Researchers have discovered that mimicking cold exposure or fasting can trigger an immune response in the body that slows ...